News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TRADE NEWS: Agilent Technologies Inc. (A) Licenses KREATECH Biotechnology B.V. Technology, Enabling First CGH Microarrays Optimized for FFPE Samples


7/9/2007 10:49:25 AM

SANTA CLARA, Calif., & AMSTERDAM, The Netherlands--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Kreatech Biotechnology B.V. announced today that Agilent has licensed novel labeling technology from Kreatech, which will optimize Agilent’s array-based comparative genomic hybridization (aCGH) platform for DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES